A Randomized, International, Multi-center, Open-label Study to Document Optimal Timing of Initiation of Dronedarone Treatment After Conversion With Loading Dose of Amiodarone in Patients With Persistent Atrial Fibrillation Requiring Conversion of AF.
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2012
At a glance
- Drugs Dronedarone (Primary) ; Amiodarone
- Indications Atrial fibrillation
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms ARTEMIS AF Loading
- Sponsors Sanofi
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 28 Jun 2012 Additional locations added as reported by European Clinical Trials Database.
- 20 Jan 2012 Actual patient number (402) added as reported by ClinicalTrials.gov.